| Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology U Tarantino, G Iolascon, L Cianferotti, L Masi, G Marcucci, F Giusti, ... Journal of orthopaedics and traumatology 18, 3-36, 2017 | 242 | 2017 |
| Calcium intake in bone health: a focus on calcium-rich mineral waters L Vannucci, C Fossi, S Quattrini, L Guasti, B Pampaloni, G Gronchi, ... Nutrients 10 (12), 1930, 2018 | 185 | 2018 |
| Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors A Falchetti, F Marini, E Luzi, F Giusti, L Cavalli, T Cavalli, ML Brandi Genetics in Medicine 11 (12), 825-835, 2009 | 114 | 2009 |
| Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database F Giusti, L Cianferotti, F Boaretto, F Cetani, F Cioppi, A Colao, MV Davì, ... Endocrine 58, 349-359, 2017 | 112 | 2017 |
| Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary data E Caletti, RA Paoli, A Fiorentini, M Cigliobianco, E Zugno, M Serati, ... Frontiers in human neuroscience 7, 661, 2013 | 112 | 2013 |
| Multiple endocrine neoplasia type 1 F Giusti, F Marini, F Tonelli, ML Brandi Principles of bone biology, 1293-1306, 2020 | 104 | 2020 |
| The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the “Knudson’s second hit” E Luzi, F Marini, F Giusti, G Galli, L Cavalli, ML Brandi PloS one 7 (6), e39767, 2012 | 98 | 2012 |
| Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo‐controlled study G Gerra, A Zaimovic, F Giusti, G Moi, C Brewer Addiction biology 7 (4), 385-395, 2002 | 98 | 2002 |
| Aggressive responding of male heroin addicts under methadone treatment: psychometric and neuroendocrine correlates G Gerra, A Zaimovic, MA Raggi, F Giusti, R Delsignore, S Bertacca, ... Drug and alcohol dependence 65 (1), 85-95, 2001 | 87 | 2001 |
| Experimentally induced aggressive behavior in subjects with 3, 4-methylenedioxy-methamphetamine (“Ecstasy”) use history: psychobiological correlates G Gerra, A Zaimovic, R Ampollini, F Giusti, R Delsignore, MA Raggi, ... Journal of substance abuse 13 (4), 471-491, 2001 | 87 | 2001 |
| Lofexidine versus clonidine in rapid opiate detoxification G Gerra, A Zaimovic, F Giusti, C Di Gennaro, U Zambelli, S Gardini, ... Journal of substance abuse treatment 21 (1), 11-17, 2001 | 78 | 2001 |
| Hereditary hyperparathyroidism syndromes F Giusti, L Cavalli, T Cavalli, ML Brandi Journal of Clinical Densitometry 16 (1), 69-74, 2013 | 77 | 2013 |
| Thyroid cancer: current molecular perspectives F Giusti, A Falchetti, F Franceschelli, F Marini, A Tanini, ML Brandi Journal of oncology 2010, 2010 | 73 | 2010 |
| Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease OME Albagha, MR Visconti, N Alonso, S Wani, K Goodman, WD Fraser, ... Journal of Bone and Mineral Research 28 (11), 2338-2346, 2013 | 65 | 2013 |
| A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome F Tonelli, F Giudici, F Giusti, F Marini, L Cianferotti, G Nesi, ML Brandi European Journal of Endocrinology 171 (2), K7-K17, 2014 | 64 | 2014 |
| Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? F Giusti, F Tonelli, ML Brandi Clinics 67, 141-144, 2012 | 62 | 2012 |
| Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update F Marini, L Cianferotti, F Giusti, ML Brandi Clinical Cases in Mineral and Bone Metabolism 14 (1), 60, 2017 | 52 | 2017 |
| Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1) F Giusti, L Cianferotti, G Gronchi, F Cioppi, L Masi, A Faggiano, A Colao, ... Endocrine 52, 495-506, 2016 | 52 | 2016 |
| Update upon the infection risk in patients receiving TNF alpha inhibitors G Murdaca, S Negrini, M Pellecchio, M Greco, C Schiavi, F Giusti, ... Expert opinion on drug safety 18 (3), 219-229, 2019 | 51 | 2019 |
| Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign L Cavalli, A Guazzini, L Cianferotti, S Parri, T Cavalli, A Metozzi, F Giusti, ... BMC musculoskeletal disorders 17, 1-11, 2016 | 47 | 2016 |
